Stay updated on CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome

Sign up to get notified when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.
Latest website image capture
Clouds background image

Latest updates to the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T13:25:58.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A notice about NIH websites’ transition from “Artificial Intelligence” to “Super Intelligence” appears above the clinical trial record.
    Difference
    0.5%
    Check dated 2026-10-24T16:36:57.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2, with the study record and its history otherwise unchanged.
    Difference
    0.1%
    Check dated 2026-10-17T16:27:49.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1, while the study record details remain unchanged.
    Difference
    0.1%
    Check dated 2026-10-10T16:29:17.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 was added to the history and the previous Revision: v3.6.6 was removed. This reflects an update to the study record's version log.
    Difference
    0.1%
    Check dated 2026-09-19T17:48:02.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The record history now shows a new Revision: v3.6.6, replacing Revision: v3.6.5, indicating an updated version of the study record on the CARDINAL page.
    Difference
    0.1%
    Check dated 2026-08-29T18:38:37.000Z thumbnail image

Stay in the know with updates to CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome

Enter your email address, and we'll notify you when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.